Pneumococcal nasopharyngeal carriage in children <5  years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel

References

• Dagan R, Patterson S, Juergens C, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin Infect Dis 2013; 57:952-62; PMID:23804191; http://dx.doi.org/10.1093/cid/cit428
   PubMed Web of Science ®Google Scholar
• Moore MR, Whitney CG. Use of pneumococcal disease epidemiology to set policy and prevent disease during 20 years of the emerging infections program. Emerg Infect Dis 2015; 21:1551-6; PMID:26291238; http://dx.doi.org/10.3201/eid2109.150395
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis 2014; 59:1724-32; PMID:25159581; http://dx.doi.org/10.1093/cid/ciu683
   PubMed Web of Science ®Google Scholar
• Park H, Adeyemi AO, Rascati KL. Direct medical costs and utilization of health care services to treat pneumonia in the United States: An analysis of the 2007-2011 Medical Expenditure Panel Survey. Clin Ther 2015; 37:1466-76 e1; PMID:26001310; http://dx.doi.org/10.1016/j.clinthera.2015.04.013
   PubMed Web of Science ®Google Scholar
• Simell B, Auranen K, Kayhty H, Goldblatt D, Dagan R, O'Brien KL. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines 2012; 11:841-55; PMID:22913260; http://dx.doi.org/10.1586/erv.12.53
   PubMed Web of Science ®Google Scholar
• Kellner JD, Scheifele D, Vanderkooi OG, Macdonald J, Church DL, Tyrrell GJ. Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada. Pediatr Infect Dis J 2008; 27:526-32; PMID:18458650; http://dx.doi.org/10.1097/INF.0b013e3181658c5c
   PubMed Web of Science ®Google Scholar
• Kuo CY, Hwang KP, Hsieh YC, Cheng CH, Huang FL, Shen YH, Huang YC, Chiu CH, Chen PY, Lin TY. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine. Vaccine 2011; 29:5171-7; PMID:21621578; http://dx.doi.org/10.1016/j.vaccine.2011.05.034
   PubMed Web of Science ®Google Scholar
• Moore MR, Hyde TB, Hennessy TW, Parks DJ, Reasonover AL, Harker-Jones M, Gove J, Bruden DL, Rudolph K, Parkinson A, et al. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis 2004; 190:2031-8; PMID:15529269; http://dx.doi.org/10.1086/425422
   PubMed Web of Science ®Google Scholar
• Loo JD, Conklin L, Fleming-Dutra KE, Knoll MD, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J 2014; 33 Suppl 2:S161-71; PMID:24336058; http://dx.doi.org/10.1097/INF.0000000000000084
   PubMedGoogle Scholar
• Usuf E, Badji H, Bojang A, Jarju S, Ikumapayi UN, Antonio M, Mackenzie G, Bottomley C. Pneumococcal carriage in rural Gambia prior to the introduction of pneumococcal conjugate vaccine: a population-based survey. Trop Med Int Health 2015; 20:871-9; http://dx.doi.org/10.1111/tmi.12505
   PubMed Web of Science ®Google Scholar
• Mackenzie GA, Leach AJ, Carapetis JR, Fisher J, Morris PS. Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. BMC Infect Dis 2010; 10:304; PMID:20969800; http://dx.doi.org/10.1186/1471-2334-10-304
   PubMed Web of Science ®Google Scholar
• Greenberg D, Givon-Lavi N, Broides A, Blancovich I, Peled N, Dagan R. The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin Infect Dis 2006; 42:897-903; PMID:16511750; http://dx.doi.org/10.1086/500935
   PubMed Web of Science ®Google Scholar
• von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C, Madhi SA, Zell ER, Verani JR, O'Brien KL, et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med 2014; 371:1889-99; PMID:25386897; http://dx.doi.org/10.1056/NEJMoa1401914
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Somekh E, Aviner S, Miron D, Dagan R. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children. Vaccine 2014; 32:3452-9; PMID:24690148; http://dx.doi.org/10.1016/j.vaccine.2014.03.065
   PubMed Web of Science ®Google Scholar
• Berglund A, Ekelund M, Fletcher MA, Nyman L. All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction. PLoS One 2014; 9:e112211; PMID:25379659; http://dx.doi.org/10.1371/journal.pone.0112211
   PubMed Web of Science ®Google Scholar
• Lindstrand A, Bennet R, Galanis I, Blennow M, Ask LS, Dennison SH, Rinder MR, Eriksson M, Henriques-Normark B, Ortqvist A, et al. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine. Pediatrics 2014; 134:e1528-36; PMID:25384486; http://dx.doi.org/10.1542/peds.2013-4177
   PubMed Web of Science ®Google Scholar
• Griffin MR, Mitchel E, Moore MR, Whitney CG, Grijalva CG. Declines in pneumonia hospitalizations of children aged <2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012. MMWR Morb Mortal Wkly Rep 2014; 63:995-8; PMID:25375070
   PubMed Web of Science ®Google Scholar
• Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. US hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369:155-63; PMID:23841730; http://dx.doi.org/10.1056/NEJMoa1209165
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MP, Harrison TG, Ladhani SN, Miller E. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England. Vaccine 2014; 32:4349-55; PMID:24657717; http://dx.doi.org/10.1016/j.vaccine.2014.03.017
   PubMed Web of Science ®Google Scholar
• Davis SM, Deloria-Knoll M, Kassa HT, O'Brien KL. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine 2013; 32:133-45; PMID:23684824; http://dx.doi.org/10.1016/j.vaccine.2013.05.005
   PubMed Web of Science ®Google Scholar
• Regev-Yochay G, Paran Y, Bishara J, Oren I, Chowers M, Tziba Y, Istomin V, Weinberger M, Miron D, Temper V, et al. Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study. Vaccine 2015; 33:1135-42; PMID:25613717; http://dx.doi.org/10.1016/j.vaccine.2015.01.030
   PubMed Web of Science ®Google Scholar
• Dagan R, Givon-Lavi N, Fraser D, Lipsitch M, Siber GR, Kohberger R. Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J Infect Dis 2005; 192:367-76; PMID:15995949; http://dx.doi.org/10.1086/431679
   PubMed Web of Science ®Google Scholar
• Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H. Colonisation endpoints in Streptococcus pneumoniae vaccine trials. Vaccine 2013; 32:153-8; PMID:24016803; http://dx.doi.org/10.1016/j.vaccine.2013.08.061
   PubMed Web of Science ®Google Scholar
• Tocheva AS, Jefferies JM, Rubery H, Bennett J, Afimeke G, Garland J, Christodoulides M, Faust SN, Clarke SC. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Vaccine 2011; 29:4400-4; PMID:21504773; http://dx.doi.org/10.1016/j.vaccine.2011.04.004
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011; 378:1962-73; PMID:21492929; http://dx.doi.org/10.1016/S0140-6736(10)62225-8
   PubMed Web of Science ®Google Scholar
• Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day care centers. Pediatr Infect Dis J 2003; 22:532-9; PMID:12799510
   PubMed Web of Science ®Google Scholar
• Grivea IN, Panagiotou M, Tsantouli AG, Syrogiannopoulos GA. Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among day-care center attendees in central Greece. Pediatr Infect Dis J 2008; 27:519-25; PMID:18469733; http://dx.doi.org/10.1097/INF.0b013e318168d28a
   PubMed Web of Science ®Google Scholar
• Cohen R, Levy C, de La Rocque F, Gelbert N, Wollner A, Fritzell B, Bonnet E, Tetelboum R, Varon E. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J 2006; 25:1001-7; PMID:17072121; http://dx.doi.org/10.1097/01.inf.0000243163.85163.a8
   PubMed Web of Science ®Google Scholar
• Azzari C, Martinon-Torres F, Schmitt HJ, Dagan R. Evolving role of 13-valent pneumococcal conjugate vaccine in clinical practice. Pediatr Infect Dis J 2014; 33:858-64; PMID:24618937; http://dx.doi.org/10.1097/INF.0000000000000328
   PubMed Web of Science ®Google Scholar
• Dagan R, Givon-Lavi N, Porat N, Greenberg D. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial. Vaccine 2012; 30:5132-40; PMID:22683519; http://dx.doi.org/10.1016/j.vaccine.2012.05.059
   PubMed Web of Science ®Google Scholar
• Greenberg D, Givon-Lavi N N N, bar-Ziv J, Dagan R. Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential. Pediatr Infect Dis J 2011; 30:227-33; PMID:20861756; http://dx.doi.org/10.1097/INF.0b013e3181f87802
   PubMed Web of Science ®Google Scholar
• Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013; 10:e1001517; PMID:24086113; http://dx.doi.org/10.1371/journal.pmed.1001517
   PubMed Web of Science ®Google Scholar
• Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Lovgren M, Tyrrell GJ, Desai S, Sherrard L, Adam H, et al. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012. Can J Microbiol 2013; 59:778-88; PMID:24313450; http://dx.doi.org/10.1139/cjm-2013-0614
   PubMed Web of Science ®Google Scholar
• Desai AP, Sharma D, Crispell EK, Baughman W, Thomas S, Tunali A, Sherwood L, Zmitrovich A, Jerris R, Satola S, et al. Decline in pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in children in Atlanta, Georgia. Pediatr Infect Dis J 2015; 34:1168-74; http://dx.doi.org/10.1097/INF.0000000000000849.
   Web of Science ®Google Scholar
• Nzenze SA, Shiri T, Nunes MC, Klugman KP, Kahn K, Twine R, de Gouveia L, von Gottberg A, Madhi SA. Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization. Pediatr Infect Dis J 2013; 32:1270-8; PMID:24061271; http://dx.doi.org/10.1097/01.inf.0000435805.25366.64
   PubMed Web of Science ®Google Scholar
• Grant LR, O'Brien SE, Weatherholtz RC, Jacobs MR, Bajaksouzian S, Reid R, et al. Reductions in PCV13-type colonization among immunized and unimmunized American Indian community members (Abstract # 478). 9th International Symposium on Pneumococci and Pneumococcal Disease (ISPPD), March 9-13, 2014, Hyderabad, India
   Google Scholar
• Grant LR, Weatherholtz RC, Hammitt LL, O'Brien KL. Reductions in PCV13-type Colonization among American Indian Community Members. 6th International Meeting on Indigenous Child Health. March 2015, Ottawa, Ontario
   Google Scholar
• Ben-Shimol S, Dagan R, Givon-Lavi N, Bar-Ziv Y, Greenberg D. Community acquired pneumonia (CAP) in children younger than 5 years of age in southern Israel. Harefuah 2010; 149:137-42, 96
   Google Scholar
• Statistical Abstracts of Israel, 2014. No. 65. Central Bureau of Statistics. Jerusalem: State of Israel, 2014
   Google Scholar
• Ben-Shimol S, Greenberg D, Hazan G, Shemer-Avni Y, Givon-Lavi N, Dagan R. Seasonality of both bacteremic and nonbacteremic pneumonia coincides with viral lower respiratory tract infections in early childhood, in contrast to nonpneumonia invasive pneumococcal disease, in the pre-pneumococcal conjugate vaccine era. Clin Infect Dis 2015; 60:1384-7; PMID:25595749
   PubMed Web of Science ®Google Scholar
• Dagan R, Givon-Lavi N, Zamir O, Sikuler-Cohen M, Guy L, Janco J, Yagupsky P, Fraser D. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 2002; 185:927-36; PMID:11920317; http://dx.doi.org/10.1086/339525
   PubMed Web of Science ®Google Scholar
• Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae. J Infect Dis 2015; 211:1144-53; PMID:25355940; http://dx.doi.org/10.1093/infdis/jiu576
   PubMed Web of Science ®Google Scholar
• Porat N, Amit U, Givon-Lavi N, Leibovitz E, Dagan R. Increasing importance of multidrug-resistant serotype 6A Streptococcus pneumoniae clones in acute otitis media in southern Israel. Pediatr Infect Dis J 2010; 29:126-30; PMID:19927039; http://dx.doi.org/10.1097/INF.0b013e3181b78e6e
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, Dagan R. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel. Vaccine 2012; 30:6600-7; PMID:22939907; http://dx.doi.org/10.1016/j.vaccine.2012.08.012
   PubMed Web of Science ®Google Scholar